Media Database
>
Riley Griffin

Riley Griffin

U.S. Health Care & Pharmaceuticals Reporter at Bloomberg News Online

Contact this person
Email address
r*****@*******.netGet email address
Influence score
66
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

bloomberg.com

Johnson & Johnson Drops Talcum Powder Globally as Lawsuits Mount

J&J to Halt Talc Baby Powder Implicated in Cancer Litigation (JNJ)  Bloomberg Johnson & Johnson drops talcum powder globally as lawsuits mount  The Indian Express Whether talcum powder is safe, and why Johnson & Johnson is replacing talc-based baby powder  iNews J&J: Why Johnson & Johnson wan stop to dey sell Talcum powder  BBC Johnson & Johnson announces end to talcum powder globally  Washington Examiner View Full Coverage on Google News
bloomberg.com

Americans Could Have to Pay for Covid Shots Starting Next Year

The US government anticipates that it won’t have funding to purchase or distribute Covid-19 vaccines as soon as January, and is planning to transition the efforts to the commercial market.
bloomberg.com

Fauci Warns of a Bad Flu Season Brewing as He Nears Office Exit

President Joe Biden’s medical adviser Anthony Fauci warned that the US should be prepared for “pretty bad flu season” coupled with continued Covid-19 cases this winter when he’ll be stepping down from his post as the nation’s top infectious disease official.
bloomberg.com

White House Warns of Pandemics Worse Than Covid as Health Overhauls...

White House health officials warned that new pandemics could prove more serious than Covid-19 in a report that reviews efforts to prepare for the “high likelihood” of future serious outbreaks.
bloomberg.com

Pfizer Needs to Prove It’s Ready to Move On From Covid-19

The drug giant believes that the technology behind its blockbuster vaccine will be the foundation of a lucrative new era, but competitors are circling and its stock is under pressure.
bloomberg.com

Tool Used to Rule Out Foul Play With Covid-19 May Spot Bioweapons

Hi, it’s Riley. I’m writing fresh off a trip to Boston where I spoke with intelligence officials about their plan to suss out man-made biological threats.
bloomberg.com

How to Move On From the Debate Over the Origins of the Pandemic

‘You’re not going to find the smoking gun’: Protecting humanity from the next pandemic means accepting both sides of a controversial debate
bloomberg.com

Covid Hospitalizations Are Rising in Kids Under 6 Months, CDC ... -...

Covid-19 hospitalizations are rising among babies under 6 months old, and the US Centers for Disease Control and Prevention is urging mothers to get vaccinated to reduce the risk of infection in those not yet eligible for shots, Director Rochelle Walensky said.
bloomberg.com

Russia’s Ukraine Claims Risk Thwarting a Global Conference on Biowe...

Hundreds of diplomats and health security experts are gathering in Geneva to grapple with the increasing risk that viruses, bacteria and other pathogens could be used as weapons. But Russia’s presence threatens to undercut their efforts.
bloomberg.com

US Says It Fears Russia May Use Biological Weapons in Ukraine - Blo...

Russia’s invasion of Ukraine has elevated US concerns that Vladimir Putin’s government could use biological weapons, according to a top US State Department official who’s in Geneva for a review of the global treaty addressing such threats.
bloomberg.com

US Extends Covid Public-Health Emergency, Maintaining Access to ......

The US government again extended the Covid-19 public health emergency, maintaining measures that have expanded access to health care for millions of Americans since the outbreak began in 2020.